Prospects for Active and Passive Immunization Against Staphylococcus aureus

This publication has 13 references indexed in Scilit:

• Lack of Wall Teichoic Acids inStaphylococcus aureusLeads to Reduced Interactions with Endothelial Cells and to Attenuated Virulence in a Rabbit Model of Endocarditis
  The Journal of Infectious Diseases, 2005
• Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX®) in hemodialysis patients
  Vaccine, 2004
• Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections
  Nature Medicine, 2004
• Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA
  Infection and Immunity, 2003
• Vaccination with Nontoxic Mutant Toxic Shock Syndrome Toxin 1 Protects againstStaphylococcus aureusInfection
  The Journal of Infectious Diseases, 2003
• Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving Hemodialysis
  New England Journal of Medicine, 2002
• Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome
  Vaccine, 2002
• Rational design of a global inhibitor of the virulence response in Staphylococcus aureus , based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC
  Proceedings of the National Academy of Sciences, 2000
• Role of Teichoic Acid in the Binding of Staphylococcus aureus to Nasal Epithelial Cells
  The Journal of Infectious Diseases, 1980
• BACTERIAL INTERFERENCE BETWEEN STRAINS OF S. aureus
  Annals of the New York Academy of Sciences, 1974